Evidence map›Paper›PMID 40423969›Full record

ArticleJAMA network open2025

Adverse Social Exposome During the Life Course and Vascular Brain Injury.

Sarah A Keller, Amanda DeWitt, W Ryan Powell, Frederick B Ketchum, Robert A Rissman, Barbara B Bendlin, Amy J H Kind

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Adverse policing as a social exposome pathway: Implications for depression, cognition, and dementia risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Review
  4. The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah A KellerCenter for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.
Amanda DeWittCenter for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.
W Ryan PowellCenter for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.
Frederick B KetchumDepartment of Neurology, University of Wisconsin School of Medicine and Public Health, Madison.
Robert A RissmanDepartment of Physiology and Neuroscience and Alzheimer's Therapeutic Research Institute, Keck School of Medicine of USC, San Diego, California.
Barbara B BendlinCenter for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.
Amy J H KindCenter for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.

Funding

The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)R01AG070883 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI AMY J. KIND · 2021 to 2026
$42.1M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Sanjay Asthana · 2019 to 2026
$34.5M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI · 2020 to 2026
$27.8M
Neighborhood Socioeconomic Contextual Disadvantage and Alzheimer's DiseaseRF1AG057784 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI BENDLIN, BARBARA BRIGITTA, KIND, AMY J. · 2017 to 2017
$3.8M
Neighborhood Socioeconomic Disadvantage and Medicare's 30-Day Rehospitalization Policy: Eliminating Rehospitalization Disparities by Informing Policy Design and ImplementationR01MD010243 · NIMHD · UNIVERSITY OF WISCONSIN-MADISON · PI KIND, AMY J. · 2015 to 2019
$2.8M
NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG070883NIA NIH HHS RF1 AG057784NIMHD NIH HHS R01 MD010243
6 · The paper itself

Abstract

Importance: The adverse social exposome, the entirety of harmful lifetime social-environmental exposures, is associated with Alzheimer disease and related dementias (ADRD) risk and may be key to informing modifiable systemic and behavioral risk interventions. With increasing emphasis to understand lifetime risk, methods are needed to measure and study social exposome relative to ADRD-related biological processes, including cerebrovascular disease. Objective: To evaluate the association between adverse social exposome and the burden of vascular brain injury (VBI) post mortem. Design, Setting, and Participants: This retrospective cohort study analyzed brain bank donors from 2 Alzheimer Disease Research Centers. Donations occurred between January 5, 2000, and August 5, 2018. Analysis was performed between January 13 and July 20, 2023. Exposures: Adverse social exposome, via geo-linked, time-concordant Area Deprivation Index (ADI) rankings for each year of a donor's lifetime. Main Outcomes and Measures: The main outcome consisted of the presence or absence of VBI indicators: infarcts, microinfarcts, hemorrhages, and white matter rarefaction. Association between cumulative or change in life-course ADI and VBI burden was evaluated using multivariate logistic regression models adjusted for sex and age at death. Results: The sample included 740 donors (417 female [56.4%]; mean [SD] age at death, 81.5 [10.3] years; mean [SD] VBI score, 0.7 [1.0]; and median life course ADI, 7.08 [IQR, 4.33-9.83]), with residential years spanning 1905 to 2018. In adjusted models, living more years in a county with an ADI ranked above the study population median was associated with increased VBI odds (adjusted odds ratio [AOR], 1.04; 95% CI, 1.03-1.05). Greater odds of VBI were identified in those with increasing ADI between youth and adulthood (AOR, 3.67; 95% CI, 3.65-3.70) and youth and older adulthood (AOR, 12.02; 95% CI, 7.87-18.35). Increased odds were found in groups with stable high median ADI from youth to adulthood (AOR, 3.08; 95% CI, 3.01-3.14) and youth to older adulthood (AOR, 8.46; 95% CI, 8.04-8.90). Conclusions and Relevance: In this cohort study of 740 brain bank donors, an association between ADI and the presence of VBI was indicated, when considering the full life course as well as specific life course periods. These results show promise for identifying geographic areas in need of targeted interventions to reduce cerebrovascular disease and ADRD risk factors.

Indexed as

Alzheimer DiseaseCerebrovascular TraumaEnvironmental ExposureAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Factors

Identifiers

PMID40423969
PMCPMC12117465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.